Rounding out the other four largest financing rounds in 2024 are proteomics company Alamar Biosciences' $128 million Series C ...

Biomy has developed its DeepPathFinder digital pathology platform to analyze images to classify cell and tissue types in specific regions.

The chemiluminescence-based immunoassay is used for the direct quantitative measurement of free testosterone in serum or plasma, with results in 48 minutes.

NEW YORK – Danaher on Thursday announced that its subsidiaries Danaher Diagnostics and Danaher Ventures have formed an investment partnership with healthcare artificial intelligence firm Innovaccer.

NEW YORK – After two years of decline in 2022 and 2023, the 360Dx Top 30 rebounded in 2024, rising 4 percent year over year.

NEW YORK – Laboratory Corporation of America said Thursday that it has inked an agreement to manage the daily operations of Inspira Health's three hospital labs in New Jersey and serve as the primary ...

NEW YORK — The World Health Organization (WHO) said on Wednesday that it has prequalified a point-of-care assay that can be used to help guide the treatment of Plasmodium vivax malaria. The Standard ...

The funding will be used to move the ARGO-HT research platform into an FDA-cleared system to support the development of diagnostic tests.

NEW YORK – Roche on Thursday announced that it has received an additional 510(k) clearance from the US Food and Drug Administration for its Roche Digital Pathology Dx whole-slide imaging system. The ...

Physicians Toxicology Laboratory had been accused of encouraging client healthcare practices to order drug tests for all patients regardless of medical need.

The NCI-led Vanguard study has selected tests from Guardant Health and ClearNote Health to move forward after a vigorous technology assessment. The company recently published data demonstrating its ...

Last week, readers were most interested in a story about the progress made by test developers toward commercializing rapid tests for sepsis.